London-based healthcare startup VitVio, which optimizes surgeries with real-time AI and computer vision, has secured $2 million in a pre-seed funding round led by LDV Capital, with support from Bek Ventures and Tiny Supercomputer Investment Company.
- Founded in 2023 by Maks Kozarzewski, Thomas Knox, and Aleks Pajewski, VitVio uses AI and computer vision to track surgeries in real-time, monitoring tools, stages, and safety protocols while providing live updates, time estimates, and alerts through integrated dashboards.
- Post-surgery, VitVio generates reports highlighting successes and areas for improvement. Its analytics help optimize scheduling, resource allocation, and cost reduction, supporting surgical teams and hospital administrators.
“By autonomously tracking surgical processes and tools, VitVio minimizes the potential for human error and adds no extra steps to the surgical process, aligning with industry experts' consensus on the importance of non-intrusive technology," co-founder and CEO at VitVio, Thomas Knox, commented.
- The Royal Orthopaedic Hospital NHS Foundation Trust, a leading institution in orthopedic care, has partnered with VitVio to pilot its AI-powered platform, aiming to improve surgical efficiency and patient care.
Details of the deal
- The pre-seed round was led by LDV Capital, a New York-based venture firm specializing in startups leveraging computer vision, machine learning, and AI to analyze visual data.
“We at LDV Capital are thrilled to partner with the brilliant team at VitVio. VitVio will deliver a leapfrog technical solution to operating theaters by leveraging computer vision and artificial intelligence which have been a core expertise of our LDV Capital firm since being founded in 2012,” claims Evan Nisselson, Founder and General Partner at LDV Capital.
- The investment also received support from Bek Ventures, which recently raised $250 million for its Fund III to back early-stage startups from Europe, particularly Central and Eastern Europe. Tiny Supercomputer Investment Company, also joined the round.
- With the new funding, VitVio will enhance its platform and roll out the technology at partner hospitals while finalizing partnerships with leading hospitals in the US, UK, and Europe.
